Introduction
Epistora Journal of Cancer Research and Oncology (EJCRO) is a premier peer-reviewed, open access journal dedicated to advancing the understanding, diagnosis, and treatment of cancer. Established to bridge laboratory discoveries with clinical applications, EJCRO serves as a global platform for oncologists, cancer researchers, and biomedical scientists to disseminate transformative findings.
The journal embraces the full spectrum of cancer research - from molecular mechanisms and tumor biology to clinical trials, surgical oncology, radiation therapy, and precision medicine. With a rigorous double-blind peer review process and rapid publication workflow, we ensure that high-impact research reaches the global community without delay. All articles are published under the CC BY 4.0 license, enabling unrestricted access, reuse and maximum societal impact.
Our commitment extends beyond traditional publishing. We actively promote translational research, interdisciplinary collaboration, and patient-centered oncology. By combining scholarly excellence with modern publishing innovations - including audio article summaries and digital preservation - EJCRO is shaping the future of cancer research communication.
Aim & Scope
Aim: To accelerate cancer research and oncology innovation by publishing high-quality, rigorously peer-reviewed research across all domains of cancer science. We aim to foster interdisciplinary dialogue, support early-career researchers and provide an inclusive open access home for transformative oncology research.
Scope: The journal welcomes original research articles, comprehensive reviews, short communications, clinical case reports, technical notes, perspectives and data papers covering, but not limited to:
Article Types
- Original Research - Full-length reports of novel cancer biology, clinical trials and translational findings. Up to 8,000 words with comprehensive methodology and statistical analysis
- Review Articles - Systematic surveys, comprehensive reviews and meta-analyses with future research directions. Up to 6,000 words
- Short Communications - Urgent findings, preliminary results and time-sensitive breakthroughs requiring rapid dissemination. Up to 2,500 words
- Clinical Case Reports - Detailed documentation of rare or instructive clinical cases with treatment outcomes and clinical implications
- Technical Notes - Methodological innovations, novel laboratory techniques and assay development for cancer research
- Perspectives - Expert viewpoints on emerging trends, policy implications, ethical considerations and future challenges in oncology
- Data Papers - Comprehensive description of high-quality datasets, including clinical databases, genomic data and biomarker repositories
Mission & Values
Accelerate cancer research innovation through trusted open access. Core principles: scientific rigour, clinical relevance, constructive peer review, rapid decisions, global accessibility without financial barriers. Bridging laboratory discoveries with clinical applications - precision oncology, immuno-oncology, and patient-centered cancer care.
Indexing & Archiving
Published content is maintained through structured digital preservation and accessibility practices designed to support long-term scholarly availability and continued research access.